High-throughput screening method of recombinant engineering protein and proteasome inhibitor
The invention belongs to the field of biomedical engineering, and provides a novel recombinant protein which comprises a fusion protein formed by a TMEM8B-a protein and a reporter protein, and a novel proteasome inhibitor can be screened with high throughput by using the recombinant protein. The inv...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
26.03.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention belongs to the field of biomedical engineering, and provides a novel recombinant protein which comprises a fusion protein formed by a TMEM8B-a protein and a reporter protein, and a novel proteasome inhibitor can be screened with high throughput by using the recombinant protein. The invention also correspondingly provides a high-throughput screening method of the proteasome inhibitor. The screening method is expected to quickly and effectively screen a new generation of proteasome inhibitor medicine which is better in effect, stronger in specificity, smaller in side effect and also plays a role in solid tumors. And for the high-throughput screening method, the whole process can be completed in a living cell state, and cell lysis or addition of an additional color development or luminescence reaction reagent is not needed, so that the high-throughput screening method is simple, convenient, rapid and accurate. The screening system constructed by the invention can be used for very conveniently scree |
---|---|
AbstractList | The invention belongs to the field of biomedical engineering, and provides a novel recombinant protein which comprises a fusion protein formed by a TMEM8B-a protein and a reporter protein, and a novel proteasome inhibitor can be screened with high throughput by using the recombinant protein. The invention also correspondingly provides a high-throughput screening method of the proteasome inhibitor. The screening method is expected to quickly and effectively screen a new generation of proteasome inhibitor medicine which is better in effect, stronger in specificity, smaller in side effect and also plays a role in solid tumors. And for the high-throughput screening method, the whole process can be completed in a living cell state, and cell lysis or addition of an additional color development or luminescence reaction reagent is not needed, so that the high-throughput screening method is simple, convenient, rapid and accurate. The screening system constructed by the invention can be used for very conveniently scree |
Author | HU QIKANG YU FENGLEI LIU WENLIANG ZENG JIN NI BIN HUANG XINGCHUN ZENG QINGJUAN WANG LI |
Author_xml | – fullname: NI BIN – fullname: ZENG QINGJUAN – fullname: WANG LI – fullname: HUANG XINGCHUN – fullname: LIU WENLIANG – fullname: HU QIKANG – fullname: YU FENGLEI – fullname: ZENG JIN |
BookMark | eNqNyjsOwjAQRVEXUPDbw7CAFBGfiBJFoFRUlEiRk7zYI5EZyzb7RwgWQHVvcZZmJipYmEfDzhfZR305H16ZUh8BYXE0IXsdSEeK6HXqWKxkgjgWIH5EiJrBQlaG79ukE4jFc8dZ49rMR_tM2Py6Mtvr5V43BYK2SMH2EOS2vpVlVR2Op3113v1j3ntpPrI |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences Physics |
DocumentTitleAlternate | 一种重组工程蛋白及蛋白酶体抑制剂的高通量筛选方法 |
ExternalDocumentID | CN117756947A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CN117756947A3 |
IEDL.DBID | EVB |
IngestDate | Fri Sep 06 06:13:59 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Chinese English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CN117756947A3 |
Notes | Application Number: CN202311760584 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240326&DB=EPODOC&CC=CN&NR=117756947A |
ParticipantIDs | epo_espacenet_CN117756947A |
PublicationCentury | 2000 |
PublicationDate | 20240326 |
PublicationDateYYYYMMDD | 2024-03-26 |
PublicationDate_xml | – month: 03 year: 2024 text: 20240326 day: 26 |
PublicationDecade | 2020 |
PublicationYear | 2024 |
RelatedCompanies | THE SECOND XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY |
RelatedCompanies_xml | – name: THE SECOND XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY |
Score | 3.6663897 |
Snippet | The invention belongs to the field of biomedical engineering, and provides a novel recombinant protein which comprises a fusion protein formed by a TMEM8B-a... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS TESTING VINEGAR WINE |
Title | High-throughput screening method of recombinant engineering protein and proteasome inhibitor |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240326&DB=EPODOC&locale=&CC=CN&NR=117756947A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NS8NAEB1q_bxpVbR-sILkFmzz2R6C2E1LEZoWqdKDULKbDY3QpDQpgr_e2W1qvegtbGBJBl5mXvbNG4D7sNmIYqyU9WZoI0GJbS5FAKbO3MhyItNtN4VscB4ETv_Vep7Ykwp8bHphlE_opzJHRERxxHuhvteL7U8sX2kr8weW4FL22Bt7vlayY2kuZzia3_G6o6E_pBqlHg204MWTZ5O207bcpx3YlWW09NnvvnVkV8rid0rpHcPeCHdLixOofM1qcEg3k9dqcDAoD7xrsK8UmjzHxRKF-Sm8S3GGXk7YWawKgtBHOopJiKwHQpMsJpLpzpnSuRCxNR0kypghSUmYRuvrMM_mgiTpLGGI7uUZ3PW6Y9rX8YGnP9GZ0mD7buY5VNMsFRdAuMENgcUPQ35hOYZo8VYUY3XSYqbh8kZ8CfW_96n_d_MKjmSkpRDLcK6hWixX4gYzc8FuVUi_AVallIU |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qfdSbVkXrawXJLdjm2R6C2E1L1TYtUqUHIWTzoBGalCZF8Nc7u02tF72FDSzJwJeZL_vNNwC3XqMeRFgpyw1PR4IS6T4XAagyMwPNCFSz1Qh5g_PAMXqv2tNEn5TgY90LI3xCP4U5IiLKR7zn4ns93_zEsoW2MrtjMS6l992xZUsFO-bmcooh2W2rMxraQypRalFHcl4sfjapGy3NfNiCbZO78_LS6a3Nu1Lmv1NK9wB2Rrhbkh9C6WtahQpdT16rwt6gOPCuwq5QaPoZLhYozI7gnYsz5GLCznyZE4Q-0lFMQmQ1EJqkEeFMd8aEzoWEG9NBIowZ4oR4SbC69rJ0FpI4mcYM0b04hptuZ0x7Mj6w-xMdlzqbd1NPoJykSXgKxFd8JcTihyG_0AwlbPrNIMLqpMlUxfTr0RnU_t6n9t_Na6j0xoO-2390ns9hn0edi7IU4wLK-WIZXmKWztmVCO83cjSXcg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=High-throughput+screening+method+of+recombinant+engineering+protein+and+proteasome+inhibitor&rft.inventor=NI+BIN&rft.inventor=ZENG+QINGJUAN&rft.inventor=WANG+LI&rft.inventor=HUANG+XINGCHUN&rft.inventor=LIU+WENLIANG&rft.inventor=HU+QIKANG&rft.inventor=YU+FENGLEI&rft.inventor=ZENG+JIN&rft.date=2024-03-26&rft.externalDBID=A&rft.externalDocID=CN117756947A |